
Veeva Systems Inc. (NYSE:VEEV) and OpenEvidence announced on Thursday that they have entered into a long-term partnership to develop and market Open Vista, an artificial intelligence platform aimed at improving clinical research and patient care.
The companies said Open Vista will leverage AI to expand patient access to clinical trials, accelerate drug discovery by identifying unmet medical needs, and enhance the understanding and adoption of approved medicines to improve patient outcomes.